Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

Tomas Kalincik, Vilija Jokubaitis, Guillermo Izquierdo, Pierre Duquette, Marc Girard, Pierre Grammond, Alessandra Lugaresi, Celia Oreja-Guevara, Roberto Bergamaschi, Raymond Hupperts, Francois Grand'Maison, Eugenio Pucci, Vincent Van Pesch, Cavit Boz, Gerardo Iuliano, Ricardo Fernandez-Bolanos, Shlomo Flechter, Daniele Spitaleri, Edgardo Cristiano, Freek VerheulJeannette Lechner-Scott, Maria Pia Amato, Jose Antonio Cabrera-Gomez, Maria Laura Saladino, Mark Slee, Fraser Moore, Orla Gray, Mark Paine, Michael Barnett, Eva Havrdova, Dana Horakova, Timothy Spelman, Maria Trojano, Helmut Butzkueven

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1159-1171
JournalMultiple Sclerosis Journal
Volume21
Issue number9
DOIs
Publication statusPublished - Aug 2015

Keywords

  • Multiple sclerosis
  • treatment outcomes
  • patient registry
  • real-world date
  • propensity score
  • relapses
  • disability

Cite this

Kalincik, T., Jokubaitis, V., Izquierdo, G., Duquette, P., Girard, M., Grammond, P., Lugaresi, A., Oreja-Guevara, C., Bergamaschi, R., Hupperts, R., Grand'Maison, F., Pucci, E., Van Pesch, V., Boz, C., Iuliano, G., Fernandez-Bolanos, R., Flechter, S., Spitaleri, D., Cristiano, E., ... Butzkueven, H. (2015). Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis. Multiple Sclerosis Journal, 21(9), 1159-1171. https://doi.org/10.1177/1352458514559865